Aalto Bio Reagents Ltd.-Biosynth’s Post

Following the outbreak of the Nipah virus in India. The Indian authorities have instituted a mass testing for the deadly virus that has killed two people in Kerela. We have developed a monoclonal antibody to screen and detect the virus. This MAb can help detect, monitor and treat the disease at source. If you are a scientist or a researcher looking at this virus please feel free to reach out to us at biologics@biosynth.com and we'll be happy to help. We also hope that everyone's safe and healthy!